<DOC>
	<DOCNO>NCT02696408</DOCNO>
	<brief_summary>The LLLT anti-inflammatory , analgesic effect accelerate heal ulcerated lesion . There little data literature show efficacy prevention mucositis cohorts patient hematopoietic stem cell transplantation . The main objective study assess efficacy prophylactic low level laser therapy severity oral mucositis HSCT .</brief_summary>
	<brief_title>Efficacy Prophylactic Low Level Laser Therapy ( LLLT ) Decreasing Severity Oral Mucositis During Hematopoietic Stem Cell ( HSC ) Transplantation</brief_title>
	<detailed_description>The main end point efficacy reduction severe mucositis ( grade 3 ) . The secondary efficacy endpoint reduction mucositis , whatever grade , reduction time mucositis , time onset mucositis symptom , reduction pain intensity evaluation quality life.The secondary endpoint safety severe adverse event potential toxicity . Patients allocate inclusion 1/1 ratio either laser-on laser-off group . In laser group , patient undergo laser therapy , consist irradiation whole oral cavity 2 minute 250mW power . In laser-off group , laser therapy carry equipment time . Protective eye shield use avoid detrimental effect eye keep subject blind .</detailed_description>
	<mesh_term>Mucositis</mesh_term>
	<mesh_term>Stomatitis</mesh_term>
	<criteria>Patient hematologic malignancy ( myeloma , lymphoma , leukemia ) . Patient undergo autologous allogeneic HSC transplantation myeloablative conditioning Patient affiliate social security Signed inform consent Patient undergoing HSCT reduce intensity conditioning Slavin ( FB2 ) Seattle ( F2 Gy TBI ) Protected Maggiore Pregnant woman Patient pacemaker Epileptic Patient</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>